---
title: "Bicara Therapeutics (BCAX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BCAX.US/norm.md"
symbol: "BCAX.US"
name: "Bicara Therapeutics"
parent: "https://longbridge.com/en/quote/BCAX.US.md"
datetime: "2026-05-20T07:12:10.409Z"
locales:
  - [en](https://longbridge.com/en/quote/BCAX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BCAX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BCAX.US/norm.md)
---

# Bicara Therapeutics (BCAX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.9258 | -0.6780 | -0.6658 | -0.5022 | -0.6766 |
| ROE | -49.12% | -37.19% | -34.68% | -24.50% | -31.00% |
| Revenue | - | - | - | - | - |
| Net income | -56.21M | -37.39M | -36.33M | -27.39M | -36.85M |
| Operating income | -60.24M | -41.12M | -40.68M | -32.02M | -41.79M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 553.60M | 430.99M | 424.69M | 453.59M | 478.08M |
| Leverage | 1.08 | 1.07 | 1.05 | 1.04 | 1.04 |
| BVPS | 7.84 | 7.37 | 7.38 | 7.98 | 8.42 |
| Turnover | - | - | - | - | - |
| Cash & STI | 539.75M | 414.80M | 290.17M | 436.61M | 462.06M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 1.77M | 2.03M | 2.10M | 2.35M | 688000.00 |
| Net debt | -538.31M | -413.09M | -288.19M | -434.37M | -461.47M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -37.51M | -23.89M | -29.25M | -25.59M | -28.11M |
| Investing CF | 100.94M | -82.33M | -236.12M | - | - |
| Financing CF | 163.34M | 31.23M | 436000.00 | 135000.00 | 460000.00 |
| Free CF | -19.35M | -13.60M | -17.47M | -17.97M | -17.37M |
| OCF coverage | -62513.33% | -10036.13% | -69638.10% | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | -60000.00 | -238000.00 | -42000.00 | - | - |